Human Plasma Like Medium Market Forecast Report: Size, Share, and Opportunities 2030

 What Are the Key Growth Indicators and Market Expansion Estimates for the Human Plasma Like Medium Market Through 2030?

 The human plasma derived products market size has grown strongly in recent years. It will grow from $0.91 billion in 2025 to $0.99 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing use of immunoglobulin therapies, growing prevalence of rare and chronic disorders, rising demand for albumin and clotting factors, expansion of plasma collection centers, and increasing awareness of plasma-derived treatments.

 
 The human plasma derived products market size is expected to see strong growth in the next few years. It will grow to $1.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growing demand for immunoglobulin therapies, rising incidence of immunodeficiency diseases, increasing healthcare expenditure on biologics, expansion of plasma fractionation capacity, and growing adoption of plasma-derived products in emerging markets. Major trends in the forecast period include technology advancements in plasma fractionation, innovation in virus inactivation methods, developments in recombinant and hybrid plasma products, research and development in next generation plasma therapies, and integration of digital systems in plasma collection and processing.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=30615&type=smp
 
 What Are the Essential Drivers Propelling the Human Plasma Like Medium Market Forward?
 The increasing demand for in-vitro diagnostics tests is expected to propel the growth of the human plasma-like medium market going forward. In-vitro diagnostics (IVD) are laboratory tests performed on biological samples such as blood, tissues, or fluids to detect diseases, monitor health status, and guide treatment decisions. The rise in in-vitro diagnostics usage is due to an aging population and higher prevalence of chronic and infectious diseases, prompting more diagnostic testing for early detection and management. The human plasma-like medium supports in-vitro diagnostics and research by supplying physiologically relevant cell culture media that researchers and laboratories require for accurate disease modeling, therapeutic development, and assay validation. For instance, in March 2025, according to NHS England, a UK-based government health authority, the number of diagnostic tests conducted in Community Diagnostic Centres increased from 1,498,000 in 2023/24 to 2,328,300 in 2024/25, marking a 55.6 % rise year over year. Therefore, the increasing demand for in-vitro diagnostics and research is driving the growth of the human plasma-like medium market.
 
 Growing Demand For Gene Therapies Fueling The Growth Of The Market Due To Advancements In Precision Diagnostics And Cell-Based Research
 
 The growing demand for gene therapies is expected to propel the growth of the human plasma-like medium market going forward. Gene therapy refers to a medical technique that involves modifying or replacing defective genes to treat or prevent diseases. The increasing demand for gene therapy is due to advancements in genetic sequencing and diagnostics, which enable precise identification of disease-causing genes for targeted treatment. Human plasma-like medium supports gene therapy by providing a physiologically relevant environment that improves the viability, growth, and function of cells used in gene delivery and testing. It enhances therapeutic effectiveness by enabling more accurate evaluation of gene expression and treatment responses under conditions that closely mimic the human body. For instance, in December 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, the Food and Drug Administration (FDA) approved six gene therapy products in 2023, up from five approvals in 2022. Therefore, the growing demand for gene therapies is driving the growth of the human plasma-like medium market.
 
 What Are the Primary Market Segments in the Human Plasma Like Medium Market?
 The human plasma like medium market covered in this report is segmented — 
 
 1) By Product Type: Liquid, Powder
 2) By Distribution Channel: Direct Sales, Distributors And Wholesalers, Online Platforms
 3) By Application: Cell Culture, Drug Discovery, Regenerative Medicine, Other Applications
 4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Hospitals And Diagnostic Laboratories, Other End-Users
 
 Subsegments:
 1) By Liquid: Cell Culture Medium, Growth Factor Supplements, Buffer Solutions, Additive Formulations, Stabilizers
 2) By Powder: Lyophilized Cell Culture Medium, Protein Supplements, Mineral Blends, Vitamin Formulations, Reconstitution Agents
 
 What New Market Trends Are Emerging in the Human Plasma Like Medium Market?
 Major companies operating in the human plasma like medium market are focusing on developing innovative culture supplements, such as scalable animal-free alternatives, to improve reproducibility, safety, and ethical compliance in cell culture and biomanufacturing workflows. A scalable animal-free alternative refers to a biologically derived growth medium component that replaces traditional animal-sourced supplements, offering consistent performance without the variability, ethical concerns, and contamination risks associated with animal products. For instance, in April 2025, PL Bioscience Inc., a US-based biotechnology company, developed the artificial human platelet lysate designed for use in cell culture applications as a scalable animal-free alternative to conventional platelet lysate and serum supplements. This engineered medium component supports robust cell proliferation and viability while eliminating reliance on animal-derived sources, making it suitable for translational research, regenerative medicine, and commercial cell therapy manufacturing.
 
 Who Are the Major Companies Operating in the Human Plasma Like Medium Market?
 Major companies operating in the human plasma like medium market are Thermo Fisher Scientific Inc., Sigma Aldrich Chemicals Private Limited, Sartorius AG, HiMedia Laboratories Private Limited, Biological Industries Israel Beit Haemek Ltd., PAN-Biotech GmbH, AMS Biotechnology (Europe) Ltd., Plasmax LLC, Avam Biotechnologies Ltd. 
 
 Get the detailed human plasma like medium market report today
 https://www.thebusinessresearchcompany.com/report/human-plasma-like-medium-market-report
 
 Which Region Holds the Largest Share of the Human Plasma Like Medium Market?
 North America was the largest region in the human plasma like medium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human plasma like medium market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company